Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 7097-7106

  Wilks, Andrew B ^a   Christian, Elizabeth C ^a   Seaman, Michael S ^a,b   Sircar, Piya ^a   Carville, Angela ^d   Gomez, Carmen E ^e   Esteban, Mariano ^e   Pantaleo, Giuseppe ^f,g   Barouch, Dan H ^b   Letvin, Norman L ^a   Permar, Sallie R ^a,c  

^a Division of Viral Pathogenesis   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g Swiss Vaccine Research Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CYTOKINE; EPITOPE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PRIMER DNA; RIBOSOME DNA; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS DNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BREAST MILK; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; LACTATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; DNA, RECOMBINANT; DNA, VIRAL; FEMALE; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENE PRODUCTS, POL; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNIZATION, SECONDARY; LACTATION; MACACA MULATTA; MAMMARY GLANDS, ANIMAL; POXVIRIDAE; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; T-LYMPHOCYTE SUBSETS; VACCINES, ATTENUATED;

EID: 78650670121     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002751     Document Type: Article

References (55)

1. Nduati, R., G. John, D. Mbori-Ngacha, B. Richardson, J. Overbaugh, A. Mwatha, J. Ndinya-Achola, J. Bwayo, F. E. Onyango, J. Hughes, and J. Kreiss. 2000. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174.
2. Taha, T. E., J. Kumwenda, S. R. Cole, D. R. Hoover, G. Kafulafula, M. G. Fowler, M. C. Thigpen, Q. Li, N. I. Kumwenda, and L. Mofenson. 2009. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J. Infect. Dis. 200:1490-1497.
3. Chasela, C. S., M. G. Hudgens, D. J. Jamieson, D. Kayira, M. C. Hosseinipour, A. P. Kourtis, F. Martinson, G. Tegha, R. J. Knight, Y. I. Ahmed, et al; BAN Study Group. 2010. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N. Engl. J. Med. 362:2271-2281.
4. Kumwenda, N. I., D. R. Hoover, L. M. Mofenson, M. C. Thigpen, G. Kafulafula, Q. Li, L. Mipando, K. Nkanaunena, T. Mebrahtu, M. Bulterys, et al. 2008. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N. Engl. J. Med. 359:119-129.
5. Thior, I., S. Lockman, L. M. Smeaton, R. L. Shapiro, C. Wester, S. J. Heymann, P. B. Gilbert, L. Stevens, T. Peter, S. Kim, et al; Mashi Study Team. 2006. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296:794-805.
6. Shapiro, R. L., M. D. Hughes, A. Ogwu, D. Kitch, S. Lockman, C. Moffat, J. Makhema, S. Moyo, I. Thior, K. McIntosh, et al. 2010. Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N. Engl. J. Med. 362:2282-2294.
7. John, G. C., B. A. Richardson, R. W. Nduati, D. Mbori-Ngacha, and J. K. Kreiss. 2001. Timing of breast milk HIV-1 transmission: a meta-analysis. East Afr. Med. J. 78:75-79.
8. Semba, R. D., N. Kumwenda, D. R. Hoover, T. E. Taha, T. C. Quinn, L. Mtimavalye, R. J. Biggar, R. Broadhead, P. G. Miotti, L. J. Sokoll, et al. 1999. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 180:93-98.
9. Richardson, B. A., G. C. John-Stewart, J. P. Hughes, R. Nduati, D. Mbori-Ngacha, J. Overbaugh, and J. K. Kreiss. 2003. Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J. Infect. Dis. 187:736-740.
10. Pillay, K., A. Coutsoudis, D. York, L. Kuhn, and H. M. Coovadia. 2000. Cell-free virus in breast milk of HIV-1-seropositive women. J. Acquir. Immune Defic. Syndr. 24:330-336.
11. Rousseau, C. M., R. W. Nduati, B. A. Richardson, M. S. Steele, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss, and J. Overbaugh. 2003. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J. Infect. Dis. 187:741-747.
12. Rousseau, C. M., R. W. Nduati, B. A. Richardson, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss, and J. Overbaugh. 2004. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J. Infect. Dis. 190:1880-1888.
13. John, G. C., R. W. Nduati, D. A. Mbori-Ngacha, B. A. Richardson, D. Panteleeff, A. Mwatha, J. Overbaugh, J. Bwayo, J. O. Ndinya-Achola, and J. K. Kreiss. 2001. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J. Infect. Dis. 183:206-212.
14. Embree, J. E., S. Njenga, P. Datta, N. J. Nagelkerke, J. O. Ndinya-Achola, Z. Mohammed, S. Ramdahin, J. J. Bwayo, and F. A. Plummer. 2000. Risk factors for postnatal mother-child transmission of HIV-1. AIDS 14:2535-2541.
15. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, et al. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860.
16. Sabbaj, S., B. H. Edwards, M. K. Ghosh, K. Semrau, S. Cheelo, D. M. Thea, L. Kuhn, G. D. Ritter, M. J. Mulligan, P. A. Goepfert, and G. M. Aldrovandi. 2002. Human immunodeficiency virus-specific CD8 (+) T cells in human breast milk. J. Virol. 76:7365-7373.
17. Permar, S. R., H. H. Kang, A. Carville, K. G. Mansfield, R. S. Gelman, S. S. Rao, J. B. Whitney, and N. L. Letvin. 2008. Potent simian immunodeficiency virusspecific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys. J. Immunol. 181:3643-3650.
18. Permar, S. R., H. H. Kang, A. B. Wilks, L. V. Mach, A. Carville, K. G. Mansfield, G. H. Learn, B. H. Hahn, and N. L. Letvin. 2010. Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys. Retrovirology 7:7.
19. Heath, L., S. Conway, L. Jones, K. Semrau, K. Nakamura, J. Walter, W. D. Decker, J. Hong, T. Chen, M. Heil, et al. 2010. Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS ONE 5: e10213.
20. Gantt, S., J. Carlsson, L. Heath, M. E. Bull, A. K. Shetty, J. Mutsvangwa, G. Musingwini, G. Woelk, L. S. Zijenah, D. A. Katzenstein, et al. 2010. Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J. Virol. 84:10812-10819.
21. Baba, T. W., V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L. A. Cavacini, M. R. Posner, H. Katinger, G. Stiegler, et al. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206.
22. Santra, S., D. H. Barouch, B. Korioth-Schmitz, C. I. Lord, G. R. Krivulka, F. Yu, M. H. Beddall, D. A. Gorgone, M. A. Lifton, A. Miura, et al. 2004. Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses. Proc. Natl. Acad. Sci. USA 101:11088-11093.
23. Harari, A., P. A. Bart, W. Stöhr, G. Tapia, M. Garcia, E. Medjitna-Rais, S. Burnet, C. Cellerai, O. Erlwein, T. Barber, et al. 2008. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses. J. Exp. Med. 205:63-77.
24. Santra, S., M. S. Seaman, L. Xu, D. H. Barouch, C. I. Lord, M. A. Lifton, D. A. Gorgone, K. R. Beaudry, K. Svehla, B. Welcher, et al. 2005. Replicationdefective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates. J. Virol. 79:6516-6522.
25. Liu, J., K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
26. Liu, J., B. A. Ewald, D. M. Lynch, M. Denholtz, P. Abbink, A. A. Lemckert, A. Carville, K. G. Mansfield, M. J. Havenga, J. Goudsmit, and D. H. Barouch. 2008. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J. Virol. 82:4844-4852.
27. Mascola, J. R., A. Sambor, K. Beaudry, S. Santra, B. Welcher, M. K. Louder, T. C. Vancott, Y. Huang, B. K. Chakrabarti, W. P. Kong, et al. 2005. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. J. Virol. 79:771-779.
28. Baig, J., D. B. Levy, P. F. McKay, J. E. Schmitz, S. Santra, R. A. Subbramanian, M. J. Kuroda, M. A. Lifton, D. A. Gorgone, L. S. Wyatt, et al. 2002. Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination. J. Virol. 76:11484-11490.
29. Kaufman, D. R., J. Liu, A. Carville, K. G. Mansfield, M. J. Havenga, J. Goudsmit, and D. H. Barouch. 2008. Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination. J. Immunol. 181:4188-4198.
30. Munoz, F. M., P. A. Piedra, and W. P. Glezen. 2003. Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. Vaccine 21:3465-3467.
31. Shahid, N. S., M. C. Steinhoff, S. S. Hoque, T. Begum, C. Thompson, and G. R. Siber. 1995. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346:1252-1257.
32. Finn, A., Q. Zhang, L. Seymour, C. Fasching, E. Pettitt, and E. N. Janoff. 2002. Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides. J. Infect. Dis. 186:1422-1429.
33. Deubzer, H. E., S. K. Obaro, V. O. Newman, R. A. Adegbola, B. M. Greenwood, and D. C. Henderson. 2004. Colostrum obtained from women vaccinated with pneumococcal vaccine during pregnancy inhibits epithelial adhesion of Streptococcus pneumoniae. J. Infect. Dis. 190:1758-1761.
34. Hahn-Zoric, M., B. Carlsson, F. Jalil, L. Mellander, R. Germanier, and L. A. Hanson. 1989. The influence on the secretory IgA antibody levels in lactating women of oral typhoid and parenteral cholera vaccines given alone or in combination. Scand. J. Infect. Dis. 21:421-426.
35. Merson, M. H., R. E. Black, D. A. Sack, A. M. Svennerholm, and J. Holmgren. 1980. Maternal cholera immunisation and scecretory IgA in breast milk. Lancet 1:931-932.
36. Mascart-Lemone, F., B. Carlsson, F. Jalil, M. Hahn-Zoric, J. Duchateau, and L. A. Hanson. 1988. Polymeric and monomeric IgA response in serum and milk after parenteral cholera and oral typhoid vaccination. Scand. J. Immunol. 28:443-448.
37. Losonsky, G. A., J. M. Fishaut, J. Strussenberg, and P. L. Ogra. 1982. Effect of immunization against rubella on lactation products. I. Development and characterization of specific immunologic reactivity in breast milk. J. Infect. Dis. 145:654-660.
38. Chakrabarti, B. K., W. P. Kong, B. Y. Wu, Z. Y. Yang, J. Friborg, X. Ling, S. R. King, D. C. Montefiori, and G. J. Nabel. 2002. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization. J. Virol. 76:5357-5368.
39. Huang, Y., W. P. Kong, and G. J. Nabel. 2001. Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J. Virol. 75:4947-4951.
40. Abbink, P., A. A. Lemckert, B. A. Ewald, D. M. Lynch, M. Denholtz, S. Smits, L. Holterman, I. Damen, R. Vogels, A. R. Thorner, et al. 2007. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J. Virol. 81:4654-4663.
41. Sun, Y., R. T. Bailer, S. S. Rao, J. R. Mascola, G. J. Nabel, R. A. Koup, and N. L. Letvin. 2009. Systemic and mucosal T-lymphocyte activation induced by recombinant adenovirus vaccines in rhesus monkeys. J. Virol. 83:10596-10604.
42. Sun, Y., J. E. Schmitz, A. P. Buzby, B. R. Barker, S. S. Rao, L. Xu, Z. Y. Yang, J. R. Mascola, G. J. Nabel, and N. L. Letvin. 2006. Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge. J. Virol. 80:10950-10956.
43. Li, M., F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, et al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79:10108-10125.
44. Sun, Y., S. Santra, J. E. Schmitz, M. Roederer, and N. L. Letvin. 2008. Magnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeys. J. Virol. 82:8812-8819.
45. McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, et al; Step Study Protocol Team. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372:1894-1905.
46. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, et al; Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-ofconcept trial. Lancet 372:1881-1893.
47. Rychert, J., and A. M. Amedee. 2005. The antibody response to SIV in lactating rhesus macaques. J. Acquir. Immune Defic. Syndr. 38:135-141.
48. Van de Perre, P., A. Simonon, D. G. Hitimana, F. Dabis, P. Msellati, B. Mukamabano, J. B. Butera, C. Van Goethem, E. Karita, and P. Lepage. 1993. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 341:914-918.
49. Kuhn, L., D. Trabattoni, C. Kankasa, M. Sinkala, F. Lissoni, M. Ghosh, G. Aldrovandi, D. Thea, and M. Clerici. 2006. Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J. Pediatr. 149:611-616.
50. Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, E. Adams, et al; MOPH-TAVEG Investigators. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361:2209-2220.
51. Imaoka, K., C. J. Miller, M. Kubota, M. B. McChesney, B. Lohman, M. Yamamoto, K. Fujihashi, K. Someya, M. Honda, J. R. McGhee, and H. Kiyono. 1998. Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J. Immunol. 161:5952-5958.
52. Pinczewski, J., J. Zhao, N. Malkevitch, L. J. Patterson, K. Aldrich, W. G. Alvord, and M. Robert-Guroff. 2005. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE. Viral Immunol. 18:236-243.
53. Wang, S. W., F. M. Bertley, P. A. Kozlowski, L. Herrmann, K. Manson, G. Mazzara, M. Piatak, R. P. Johnson, A. Carville, K. Mansfield, and A. Aldovini. 2004. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. AIDS Res. Hum. Retroviruses 20:846-859.
54. Sabbaj, S., M. K. Ghosh, B. H. Edwards, R. Leeth, W. D. Decker, P. A. Goepfert, and G. M. Aldrovandi. 2005. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. J. Immunol. 174:2951-2956.
55. Amedee, A. M., N. Lacour, and M. Ratterree. 2003. Mother-to-infant transmission of SIV via breast-feeding in rhesus macaques. J. Med. Primatol. 32:187-193.